Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
04/2010
04/15/2010US20100093838 Regulation of angiogenesis with zinc finger proteins
04/15/2010US20100093837 Microrna molecules
04/15/2010US20100093832 Modulation of insulin like growth factor i receptor expression in cancer
04/15/2010US20100093831 Nucleic acid compounds for inhibiting angiogenesis and tumor growth
04/15/2010US20100093828 Compounds for the treatment of proliferative disorders
04/15/2010US20100093825 Bicycloester derivative
04/15/2010US20100093818 Benzimidazole derivatives
04/15/2010US20100093812 Desferrithiocin polyether analogues
04/15/2010US20100093797 Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
04/15/2010US20100093794 Use of a Compound in Obtaining Cytoskeleton Blockage and Cell Elongation
04/15/2010US20100093777 Spiro-ring compound
04/15/2010US20100093776 Organic Compounds and Their Uses
04/15/2010US20100093774 5-substituted quinazolinone derivatives and compositions comprising and methods of using the same
04/15/2010US20100093773 Methods of treating cancer
04/15/2010US20100093769 Compounds
04/15/2010US20100093768 Agents for Reversing Epigenetic Silencing of Genes
04/15/2010US20100093767 Mitotic Kinase Inhibitors
04/15/2010US20100093766 Novel compounds
04/15/2010US20100093765 Novel compounds
04/15/2010US20100093760 Methods for identifying compounds that modulate cell signaling and methods employing such compounds
04/15/2010US20100093743 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
04/15/2010US20100093738 Fungicidal Compounds and Fungicidal Compositions
04/15/2010US20100093737 Nucleoside and Nucleotide Analogues with Quaternary Carbon Centers and Methods of Use
04/15/2010US20100093727 Compounds and methods of use
04/15/2010US20100093718 Compounds
04/15/2010US20100093716 Therapeutic methods using wrn binding molecules
04/15/2010US20100093713 Beta-carbolines useful for treating inflammatory disease
04/15/2010US20100093708 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010US20100093696 2-amino pyrimidine compounds
04/15/2010US20100093690 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
04/15/2010US20100093688 Porphyrin catalysts and methods of use thereof
04/15/2010US20100093684 Synergistic interaction of notch-1 inhibitors with glucocorticoids
04/15/2010US20100093677 Method of inducing negative chemotaxis
04/15/2010US20100093674 Skin cancer prevention method and product
04/15/2010US20100093671 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010US20100093668 N,n'-2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitors
04/15/2010US20100093647 Mgmt inhibitor combination for the treatment of neoplastic disorders
04/15/2010US20100093645 SMAC Peptidomimetics and the Uses Thereof
04/15/2010US20100093642 Novel polypeptides
04/15/2010US20100093635 Agonists of Guanylate Cyclase UseFul For The Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
04/15/2010US20100093629 Genes and polypeptides relating to human pancreatic cancers
04/15/2010US20100093626 Peptide and small molecule agonists of epha and their uses in disease
04/15/2010US20100093625 Smoothened polypeptides and methods of use
04/15/2010US20100093614 Novel Composition for Tumor Growth Control
04/15/2010US20100093612 Integrin targeted cyclopeptide ligands, their preparation and use
04/15/2010US20100093610 Romidepsin-based treatments for cancer
04/15/2010US20100093609 Prodrugs of triciribine and triciribine phosphate
04/15/2010US20100093003 Methods to impair hematologic cancer progenitor cells and compounds related thereto
04/15/2010US20100092997 Method of Enhancing of Binding Activity of Antibody Composition to FcGamma Receptor IIIa
04/15/2010US20100092579 Medicament for treating lung cancer
04/15/2010US20100092578 Protein kinase c iota
04/15/2010US20100092568 Drug microparticles
04/15/2010US20100092559 Boldine compounds for promoting bone growth
04/15/2010US20100092545 Polyethylene-oxide based films and drug delivery systems made therefrom
04/15/2010US20100092540 Drug delivery compositions and medical devices containing block copolymer
04/15/2010US20100092539 Fluorinated GHRH Antagonists
04/15/2010US20100092524 Modification of exosomal components for use as a vaccine
04/15/2010US20100092523 Molecules and methods for treatment and detection of cancer
04/15/2010US20100092522 Immunogenic wt-1 peptides and methods of use thereof
04/15/2010US20100092519 Compositions comprising polysaccharide conjugates and their use as vaccines
04/15/2010US20100092499 Alpha Thymosin Peptides as Cancer Vaccine Adjuvants
04/15/2010US20100092498 Anti-Tumour Vaccine Derived from Normal Chemically Modified Cells
04/15/2010US20100092496 drug-ligand conjugates that are potent cytotoxins; stabilized therapeutic agents and markers; exhibit high specificity of action, reduced toxicity, and improved stability in blood ; antitumors
04/15/2010US20100092495 Potent cell-binding agent drug conjugates
04/15/2010US20100092492 Vascular endothelial cell growth factor antagonists
04/15/2010US20100092491 Anti-epcam antibody and uses thereof
04/15/2010US20100092490 Method for assay on the effect of vascularization inhibitor
04/15/2010US20100092489 Combination treatment of cd38-expressing tumors
04/15/2010US20100092480 Modulators of protein phosphatase 2a
04/15/2010US20100092479 Compositions and methods for treatment of viral diseases
04/15/2010US20100092477 Methods and compositions for treating prostate cancer
04/15/2010US20100092475 Treatment method using egfr antibodies and src inhibitors and related formulations
04/15/2010US20100092474 Pharmaceutical combinations
04/15/2010US20100092470 Antibodies, analogs and uses thereof
04/15/2010US20100092466 Combination of zd6474 and bevacizumab for cancer therapy
04/15/2010US20100092462 Methods for Suppressing Toll-Like Receptor Activity
04/15/2010US20100092461 Remedy For Chemotherapy-Resistant Cancer Containing HLA Class I-Recognizing Antibody as the Active Ingredient and Use of the Same
04/15/2010US20100092459 Protein Complex and Uses
04/15/2010US20100092457 Diagnosis and Treatment of Cancer Using Anti-Desmoglein-3 Antibodies
04/15/2010US20100092455 Novel anti-proliferation antibodies
04/15/2010US20100092445 Adoptive immune cells for tumor vaccines
04/15/2010US20100092444 Platelet rich plasma formulations for cardiac treatments
04/15/2010US20100092436 Compositions and methods for restoring immune responsiveness in patients with immunological defects
04/15/2010US20100092430 Attenuated oncolytic paramyxoviruses encoding avian cytokines
04/15/2010US20100092422 Poly (ß-hydroxy short-medium chain fatty acid)
04/15/2010US20100092388 Anthracycline Derivatives
04/15/2010DE102008047128A1 Verwendung von cis-Imidazolinen, insbesondere Nutlinen, zur Behandlung von chemoresistenten Krebserkrankungen Using cis-imidazolines, Nutlinen particular, for the treatment of chemoresistant cancer
04/15/2010CA2740148A1 Activators of human pyruvate kinase
04/15/2010CA2740046A1 Detection of granulosa-cell tumors
04/15/2010CA2739918A1 Methods for inducing a sustained immune response against a b-cell idiotype using autologous anti-idiotypic vaccines
04/15/2010CA2739788A1 Telomerase inhibitors that bind to the cr4-cr5 domain of the rna component of human telomerase and methods of use thereof
04/15/2010CA2739782A1 Imidazopyridazinecarbonitriles useful as kinase inhibitors
04/15/2010CA2739757A1 Hpma - docetaxel or gemcitabine conjugates and uses therefore
04/15/2010CA2739527A1 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer
04/15/2010CA2738983A1 Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides
04/15/2010CA2736322A1 3,3', 4,4'-tetrahydroxy-2,2' -bipyridine-n,n' -dioxides for the treatment of renal cell carcinoma
04/15/2010CA2736097A1 Carbazole compounds and therapeutic uses of the compounds
04/15/2010CA2733262A1 Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
04/14/2010EP2175016A1 Anti-prominin-1 antibody having adcc activity or cdc activity
04/14/2010EP2174958A1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature
1 ... 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 ... 2211